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Abstract
Background: Many patients with several concurrent medical conditions (multimorbidity) are seen in the
primary care setting. A thorough understanding of outcomes associated with multimorbidity would benefit
primary care workers of all disciplines. The purpose of this systematic review was to clarify the relationship
between the presence of multimorbidity and the quality of life (QOL) or health-related quality of life
(HRQOL) of patients seen, or likely to be seen, in the primary care setting.
Methods: Medline and Embase electronic databases were screened using the following search terms for
the reference period 1990 to 2003: multimorbidity, comorbidity, chronic disease, and their spelling
variations, along with quality of life and health-related quality of life. Only descriptive studies relevant to
primary care were selected.
Results: Of 753 articles screened, 108 were critically assessed for compliance with study inclusion and
exclusion criteria. Thirty of these studies were ultimately selected for this review, including 7 in which the
relationship between multimorbidity or comorbidity and QOL or HRQOL was the main outcome
measure. Major limitations of these studies include the lack of a uniform definition for multimorbidity or
comorbidity and the absence of assessment of disease severity. The use of self-reported diagnoses may
also be a weakness. The frequent exclusion of psychiatric diagnoses and presence of potential confounding
variables are other limitations. Nonetheless, we did find an inverse relationship between the number of
medical conditions and QOL related to physical domains. For social and psychological dimensions of QOL,
some studies reveal a similar inverse relationship in patients with 4 or more diagnoses.
Conclusions: Our findings confirm the existence of an inverse relationship between multimorbidity or
comorbidy and QOL. However, additional studies are needed to clarify this relationship, including the
various dimensions of QOL affected. Those studies must employ a clear definition of multimorbidity or
comorbidity and valid ways to measure these concepts in a primary care setting. Pursuit of this research
will help to better understand the impact of chronic diseases on patients.
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Background
With technological advances and improvements in medi-
cal care and public health policy, an increasingly large
number of patients survive medical conditions that used
to be fatal. As a result of this phenomenon, and parallel to
the aging of the population, a growing proportion of pri-
mary care patients presents with multiple coexisting med-
ical conditions. From available data, it was estimated that
57 million Americans had multiple chronic conditions in
2000 and that this number will rise to 81 million by 2020
[1]. Epidemiological data from several countries support
this estimate [2-8]. On average, patients aged 65 years and
older present with 2.34 chronic medical conditions [7]. In
fact, 50% of patients with a chronic disease have more
than one condition [9].
The terms "comorbidity" and "multimorbidity" have
been used to describe this phenomenon. Feinstein [10]
originally described comorbidity as "any distinct addi-
tional entity that has existed or may occur during the clin-
ical course of a patient who has the index disease under
study." Kraemer [11] later referred to comorbidity in stud-
ying specific pairs of diseases. Van den Akker and col-
leagues [12] further refined both concepts, reserving the
term "multimorbidity" to describe the co-occurrence of
two or more chronic conditions; they also proposed some
qualifiers to better classify the type of multimorbidity
(simple, associative and causal). Unfortunately, much
confusion still exists in the literature, where the 2 terms
often seem to be used interchangeably. For the purpose of
this paper, the term "multimorbidity" will be used accord-
ing to Van den Akker and colleagues' definition and the
focus will be solely on chronic diseases.
Previous reports on multimorbidity or comorbidity have
documented that this phenomenon influences outcomes
in many areas of health care [13-19]. Outcome measures
that have been related to multimorbidity include mortal-
ity, length of hospital stay, and readmission. An associa-
tion between disability and multimorbidity in elderly
patients has also been described [14,20-22].
Quality of life (QOL) is an outcome measure that is
increasingly being used to evaluate outcomes in clinical
studies of patients with chronic diseases [23-26]. QOL
represents a subjective concept, with a multidimensional
perspective encompassing physical, emotional, and social
functioning [27]. It is important to address QOL as it has
been associated with health and social outcomes [28]
which may contribute to the worsening of the course of
the diseases. In research and the medical literature, there
is little distinction between health-related quality of life
(HRQOL) and overall QOL (the latter encompasses not
only health-related factors but also many non medical
phenomena such as employment, family relationships,
and spirituality) [29]. In practice, the terms are often used
interchangeably. Different evaluation scales have been
proposed to measure QOL or HRQOL. Some focus on a
specific disease [30,31], while others have wider applica-
tions (i.e., generic measurements) [32-34].
Little is known about the impact of multimorbidity on
QOL of primary care patients [35], although this is where
most patients receive their care. Thus, the purpose of this
systematic review is to clarify the association between the
presence of several concurrent medical conditions and the
QOL or HRQOL of patients seen or likely to be seen in a
primary care setting.
Methods
Data sources
For this review, we consulted Medline and Embase elec-
tronic databases for the reference period 1990 to 2003.
Figure 1 illustrates the search strategy. Since the term
"multimorbidity" does not have any equivalent in the the-
saurus, databases were searched for the following terms:
multimorbidity, comorbidity, and their spelling varia-
tions. The term "multimorbidity" was searched as a key-
word, while "comorbidity" was searched as a Medical
Subject Heading (MeSH). The term "chronic disease" was
used to increase the sensitivity of the search. We also used
the MeSH "quality of life" and the keyword "health-
related quality of life" to help target pertinent literature.
To identify studies pertinent to the primary care setting,
the following search terms were used: general practice,
family practice, family medicine, family physician, and
primary health care. A parallel strategy was used to iden-
tify all descriptive studies, regardless of the context of care,
and the results were then combined. For the initial screen-
ing, the search was restricted to studies on human sub-
jects, published in French or English. To be complete, we
directly searched the Quality of Life Research and Health
and Quality of Life Outcomes journals. We also screened ref-
erences from key articles retrieved (hand searching).
Study selection
One researcher (LL) performed the initial screening. Any
ambiguous findings were discussed with the lead investi-
gator (MF) and a consensus was reached.
Inclusion and exclusion criteria
For the purpose of this systematic review, we selected orig-
inal, cross-sectional, and longitudinal descriptive studies
that had evaluated the relationship between multimor-
bidity or comorbidity and QOL or HRQOL as the main
outcome of interest. As stated earlier, we focused on the
population of patients seen, or likely to be seen, in the pri-
mary care setting including members of the general popu-
lation and residents of nursing homes and homeHealth and Quality of Life Outcomes 2004, 2:51 http://www.hqlo.com/content/2/1/51
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healthcare facilities. We also selected original descriptive
studies that had examined the relationship between mul-
timorbidity or comorbidity and QOL or HRQOL as a sec-
ondary outcome.
Selection of articles: Medline (Embase), years 1990–2003 Figure 1
Selection of articles: Medline (Embase), years 1990–2003
Comorbidity or multimorbidity
or chronic disease
n = 159,755 (36,233)
Primary care
n = 60 (70) 
Descriptive studies 
n = 609 (402)
Quality of life
or health-related quality of life
n = 39,676 (43,554)
 Articles screened
n = 753
Quality of Life 
Research Journal
and Health and
Quality of Life 
Outcomes
n = 4 Articles evaluated
n = 108
 From references
of key articles
n = 25
Articles included
in the systematic
review
n = 30
Articles excluded:
outcome of 
interest was not
quality of life or
nonstandard
measurement of 
quality of life was
used
n = 12
Articles excluded:
studies
examining
exclusively
mental disorders
n = 8 
Articles excluded:
populations or 
diseases did not
reflect the clinical
practice of 
primary care at
large
n = 17 
Articles not 
included because
they did not meet 
the inclusion
criteria
n = 41 
Secondary
outcome
n = 23 [refs 43-
65]
Primary
outcome
n = 7 [refs 36-42]Health and Quality of Life Outcomes 2004, 2:51 http://www.hqlo.com/content/2/1/51
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Figure 1 shows our exclusion criteria. In keeping with our
objectives, we did not include studies on specific diseases
(e.g., acquired immunodeficiency disease) or populations
unlikely to represent a large part of primary care practice.
We also excluded any studies that did not address physical
comorbidities, including those that exclusively examined
mental disorders and associated mental comorbidities.
Finally, we excluded studies in which the main outcome
of interest was not QOL or HRQOL as well as those that
used a nonstandard approach to measuring QOL or
HRQOL.
Assessment of study quality
Before being included in the synthesis, the quality of each
article selected was critically analyzed. For this assess-
ment, we devised a scale in which points were assigned for
study parameters indicative of good quality (e.g., well-
defined populations, clear definitions, valid measures).
Using this scale (Table 1), 2 researchers independently
determined a global quality score for each article. The
scores for each article were then compared and adjusted
by consensus. To ensure adequate methodological qual-
ity, the cut-off score for an article to be included in the
synthesis was 10 out of a maximum of 20 points.
Synthesis or results
Figure 1 shows the number of articles found at each stage
of the selection process. Of the 753 articles screened, 108
were evaluated according to the study's inclusion and
exclusion criteria. We also assessed the quality of each
study before selecting 30 for inclusion in the synthesis: 7
that had evaluated the relationship between multimor-
bidity or comorbidity and QOL as the main outcome
(Table 2) and 23, as a secondary outcome.
Quality of life as the main outcome measure
Of the 7 studies that featured QOL as a primary outcome
[36-42], 5 had been conducted in European populations.
We analyzed theses studies in detail. Quality scores for
these studies ranged from 10 to 18 (out of a maximum of
20 points) and were highest in 2 studies from the Nether-
lands, one from the United States, and another study from
Sweden. Table 2 presents a synthesis of the various
studies.
All studies came to the same conclusion, namely that
there is an inverse relationship between the number of
medical conditions and QOL or HRQOL. This association
may be affected by the patient's age or gender. Whereas
multimorbidity mostly affects physical dimensions of
QOL or HRQOL [36,37,41], data from one study suggest
that social and psychological dimensions may be affected
in patients with 4 or more diagnoses [40].
In each study, investigators relied on simple count of
chronic diseases from a limited list to measure multimor-
bidity. The chronic conditions included in this list varied
among the studies, and no attempt was ever made to
assess or account for the severity of each condition. Fur-
thermore, 5 of the 7 studies did not consider psychiatric
comorbidity, either because the illnesses considered did
not include psychiatric diagnoses or because patients pre-
senting with psychiatric diagnoses were excluded from the
QOL evaluation. In most cases, the diagnostic
information was obtained by a questionnaire that was
completed by a nurse or a doctor or sometimes self-
administered. One study assessed comorbidity via chart
review.
Table 1: Evaluation criteria
Evaluation criteria for the studies identified in the literature search: 0, 1, or 2 points per criterion or subcriterion (maximum score = 20)
Criterion1: Originality
Original study (cross-sectional or longitudinal) with a clear objective
Criterion 2: Population studied
2a) Primary care or general population
2b) Well-defined control group or good variability of the independent variable in a regression model
2c) Characteristics of the groups are described, including those of nonrespondents, and do not lead to bias
Criterion 3: Definition
Clear definition of multimorbidity and valid measure
Criterion 4: Outcome
4a) Quality of life was the primary outcome measure
4b) Quality of life was evaluated with a validated scale
4c) Evaluation of quality of life was independent of the multimorbidity/comorbidity score (i.e., blind evaluation)
4d) Effects of the main confounding factors (e.g., age, gender) are presented and discussed
Criterion 5: Limitations
Authors comprehensively discussed the limitations of their studyHealth and Quality of Life Outcomes 2004, 2:51 http://www.hqlo.com/content/2/1/51
Page 5 of 12
(page number not for citation purposes)
To measure QOL, a variety of scales were used. Most stud-
ies (5/7) used tools from the Medical Outcomes Study i.e.,
the Short-Form-36 Health Survey (SF-36) and Short-
Form-20 Health Survey (SF-20). However, the Notting-
ham Health Profile (NHP) was used in one study and the
European Organisation for Research and Treatment of
Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
was used in another. Although the number of domains
explored varied from one study to the next, the measuring
instruments used have excellent psychometric properties
and validity.
The 4 studies associated with the highest quality scores
explored only a limited number of potential confounders,
namely age [37,38], gender [36,41], and socio-demo-
graphic and economic factors [38]. Effects of these con-
founders are reported in Table 2. The other 3 studies did
not investigate potential confounders.
Quality of life as a secondary outcome measure
Of the 23 studies that evaluated the relationship between
multimorbidity or comorbidity and QOL as a secondary
outcome measure [43-65], most were done in Europe (9
studies) and the United States (12 studies). As with the
main outcome studies, each used a simple count of a lim-
ited and varying number of chronic medical conditions to
evaluate multimorbidity. While there was generally no
attempt to assess or account for the severity of individual
conditions, one study used a comorbidity index, the Duke
Severity of Illness (DUSOI), for this purpose [48]. Diag-
nostic information was obtained from chart reviews and
clinical evaluations (9 studies), from self-report question-
naires (13 studies), or both sources (1 study). Psychiatric
comorbidity was evaluated in 13 studies.
As with the results from the main outcome studies, we
found an inverse relationship between the number of
medical conditions and the QOL relating to physical
domains in all studies. However, the relationship between
multimorbidity and QOL relating to psychological or
social domains was less clear. Some investigators reported
an effect of multimorbidity on these domains in patients
with 3 or more diagnoses [54], while others reported no
effect [48,55].
As in the main outcome studies, tools from the Medical
Outcomes Study, including the SF-36 (17 studies), SF-20
(3 studies), and Short-Form-12 Health Survey (SF-12) (1
study), were used to evaluate QOL in most of these stud-
ies. However, the NHP was used in one study and the
Quality of Well-Being Scale (QWB), in another. In the
majority of studies, all of the QOL domains were
explored.
Discussion
Although this systematic review confirms the inverse rela-
tionship between multimorbidity and QOL, it also raises
some important questions. First, the relative lack of stud-
ies in primary care evaluating the association between
multimorbidity and QOL or HRQOL is surprising given
the number of patients who suffer from multiple concur-
rent chronic conditions. Although the existence of this
association makes logical sense, it still has to be demon-
strated and thoroughly studied to find ways of improving
care for specially affected patients. Thus, the pressing
question may not be whether there is an association but
rather how strong is the association and what factors are
responsible for it? Identifying these factors may contribute
to better care for the affected patients. There is a clear need
for further studies to address these issues.
Ultimately, multimorbidity has the potential to affect all
domains of QOL. However, the influence of multimor-
bidity on the social and psychological dimensions of QOL
is much less clear than its influence on the physical
domains. It is noteworthy that several studies showed a
significant decline in social and psychological dimensions
of QOL in patients with 3, 4, or more concurrent diag-
noses. What does this finding mean? Is there any bias that
can explain this difference, or is it related to a certain
capacity for adaptation? Are there other factors associated
with this finding? All of these questions have yet to be
answered.
All the studies examined were cross-sectional in nature.
The effect of multimorbidity may vary over time. Some
medical conditions may improve while others worsen
resulting in various effects on QOL. Therefore, cross-sec-
tional studies may not capture the real effect of multimo-
bidity on QOL and predict the direction of change over
time.
Defining and measuring multimorbidity
The absence of a uniform way of defining and measuring
multimorbidity is of special concern and may explain
some of the variability in our results. In most of the stud-
ies we evaluated, investigators had used only a simple list
of diseases to identify concurrent medical conditions in
patients, providing very incomplete information. Further-
more, the numbers and types of medical conditions in
these lists varied among the studies, precluding
comparisons.H
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Table 2: Synthesis of studies on multimorbidity with quality of life as the main outcome measure
Author
(Country)
Design Score Population Multimorbidity QOL scale Limitations Conclusions
Cheng 2003 [36] 
(United States)
Cross-sectional 
design
17 Ambulatory, family 
medicine.
n = 316 (55–64 years)
7 diagnoses of chronic 
conditions obtained by 
chart review.
Medical Outcomes 
Study (SF-36).
Administered by 
interviewer.
Definition of 
multimorbidity was based 
on simple count of diseases. 
No assessment of disease 
severity or use of a healthy 
group for comparison.
No mention of psychiatric 
comorbidity.
Limited to low-income 
population. Small sample.
Age of the sample was 
limited.
For every SF-36 domain, 
scores obtained in 
pregeriatric patients are 
significantly lower than 
those obtained in the 
general population. Lower 
physical component 
summary scores (PCS) and 
mental component 
summary scores (MCS) are 
associated with a greater 
number of chronic 
diseases, but this 
association is much 
stronger for PCS than 
MCS.
Wensing 2001 [37] 
(Netherlands)
Cross-sectional 
design
18 Ambulatory, family 
medicine.
n = 4,112 (18+ years)
25 diagnoses of chronic 
conditions, with the 
possibility of including 
other diagnoses reported 
spontaneously.
Self-administered 
questionnaire.
Medical Outcomes 
Study (SF-36); 8 
domains.
Self-administered.
Definition of 
multimorbidity was based 
on simple count of diseases. 
Medical conditions were 
self-reported by patient, 
with no assessment of 
disease severity. Psychiatric 
comorbidity was not 
evaluated.
Prevalences of chronic 
conditions were abnormally 
low, consistent with a 
selection or information 
bias.
The QOL in each of the 
domains declines with the 
number of diagnoses (0, 1, 
2 and over) but less so for 
the mental health domain.
The QOL score declines 
with age, especially in 
physical domains.
Michelson 2001 
[38] (Sweden)
Cross-sectional 
design
16 General adult population, 
stratified according to 
age.
n = 3,069 (18–79 years)
13 diagnoses of chronic 
conditions, divided into 4 
categories based on the 
number of problems: (0, 
1–2, 3–4, 5+).
Self-administered 
questionnaire.
European Organization 
for Research and 
Treatment of Cancer 
Quality of Life 
Questionnaire (EORTC 
QLQ); 5 domains.
Self-administered.
Too few diagnoses 
considered. Medical 
conditions were self-
reported by patients, with 
no assessment of disease 
severity. Psychiatric 
comorbidity was not 
evaluated.
Although adequate for use 
as a generic measure, the 
QOL questionnaire was 
developed for cancer 
patients.
The presence of multiple 
chronic problems is 
associated with a lower 
QOL score. This 
association is present for 
each age group and tends 
to reduce the relationship 
between age and QOL.
The impact of socio-
demographic and economic 
factors varies with age.H
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Cuijpers 1999 [39] 
(Nether-lands)
Cross-sectional 
design at the 
beginning of a 
cohort study
10 Residents of homes for 
the elderly. n = 211 
(Mean = 84.3 years)
7 diagnoses of chronic 
conditions, with the 
possibility of including 
other diagnoses reported 
spontaneously.
Questionnaire 
administered by the 
nursing staff.
Short-Form-20 Health 
Survey (SF-20); 5 
domains.
Administered by 
interviewer.
Too few diagnoses 
considered. No assessment 
of disease severity.
Psychiatric comorbidity was 
not evaluated.
Data collection procedure 
was not standardized.
Many refusals to participate 
(30%), including some for 
health reasons.
Small sample. Aged 
patients.
A lower QOL score is 
associated with a high 
number of chronic 
conditions.
Grimby and 
Svanborg 1997 [40] 
(Sweden)
Cross-sectional 
design in a cohort 
follow-up
14 General ambulatory. n = 
565 (76 years)
16 diagnoses of chronic 
conditions present in > 
5%.
Medical questionnaire.
Modified Nottingham 
Health Profile (NHP); 
part I: 6 dimensions; 
part II: 5 questions.
Self-administered.
Definition of 
multimorbidity was based 
on a simple count of 
diseases. No assessment of 
disease severity.
Health of nonrespondents 
was not comparable (more 
ill).
No age variation (76 years).
The loss of QOL is 
proportional to the 
number of diagnoses for 
the dimensions of energy, 
pain, mobility, and sleep. 
For social and emotional 
dimensions, QOL is little 
influenced until health is 
significantly impaired (4 or 
more diagnoses).
Kempen 1997 [41] 
(Nether-lands)
Cross-sectional 
design at the 
beginning of a 
cohort study
17 Ambulatory, family 
medicine. n = 5,279 (57+ 
years)
18 diagnoses of chronic 
conditions.
Questionnaire 
administered by 
interviewer.
Short-Form-20 Health 
Survey (SF-20); 6 
domains.
Administered by 
interviewer or self-
administered.
Definition of 
multimorbidity was based 
on simple count of diseases 
reported by the patient.
Use of a list of diagnoses in 
correlation and multiple 
regression analyses.
No assessment of disease 
severity or psychiatric 
comorbidity.
Age of the sample was 
limited.
The presence of chronic 
medical conditions explains 
a high proportion of the 
variance (25%) in the QOL 
score in most domains, 
especially self-perceived 
health. Personality 
influences QOL scores, 
especially in the mental 
health domain.
The association between 
the number of chronic 
conditions and the QOL 
score is slightly stronger 
for women than men.
Table 2: Synthesis of studies on multimorbidity with quality of life as the main outcome measure (Continued)H
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Fryback 1993 [42] 
(United States)
Cross-sectional 
design
13 General ambulatory. n = 
1,356 (45–89 years)
28 diagnoses of chronic 
conditions, with the 
possibility of including 
other diagnoses reported 
spontaneously.
Questionnaire 
administered by 
interviewer.
Medical Outcomes 
Study (SF-36) reduced 
to 2 domains.
Quality of Well-Being 
scale (QWB).
Administered by 
interviewer.
Definition of 
multimorbidity was based 
on a simple count of 
diseases reported by 
patient. No assessment of 
disease severity.
QOL questionnaire 
completed by the same 
interviewer immediately 
after the medical 
questionnaire.
Characteristics of the 
healthy group were not 
described.
Multimorbidity data were 
not adjusted for age.
Questionnaire did not 
include all domains 
traditionally included in 
QOL assessment.
The QOL score, as 
estimated with all of the 
measuring instruments, 
decreases with the number 
of chronic medical 
conditions. However, only 
limited domains of QOL 
were evaluated.
QOL: Quality of life
Table 2: Synthesis of studies on multimorbidity with quality of life as the main outcome measure (Continued)Health and Quality of Life Outcomes 2004, 2:51 http://www.hqlo.com/content/2/1/51
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Given the urgent need for conceptual clarity, Van den
Akker and colleagues' definition of multimorbidity
should be refined and advanced to achieve a common
understanding. A distinction must be made between
simple and complex chronic diseases. Treated hypothy-
roidism (simple) and ischemic heart disease (complex)
obviously do not have the same impact on QOL. Moreo-
ver, the influence of single-organ versus multi-organ dis-
eases needs to be appropriately weighed. Additional
factors to be considered when defining multimorbidity
include the severity of the conditions and the presence or
absence of associated pain.
The use of self-reported diagnoses in many studies is
another methodological limitation that may have intro-
duced error. Patients may confuse symptoms and minor
ailments with more significant disease states or may forget
to report important diagnoses that are still active. Self-
reporting may even be completely inaccurate in the pres-
ence of psychosomatic disorders. Conducting a chart
review, clinical interview or using any specific standard-
ized method may be a better way to obtain data related to
diagnoses.
Another methodological limitation of most of the studies
evaluated was their failure to consider the influence of
psychiatric comorbidity. This was either because psychiat-
ric diagnoses were not included in the lists of disease
states or because patients presenting with psychiatric diag-
noses were excluded from QOL assessment. Given the
importance of psychiatric conditions in primary care prac-
tice with a prevalence of more than 20% [66], this limita-
tion is simply unacceptable.
Confounders
QOL tends to decrease with age [67], whereas the number
of diagnoses increases with age. Thus, it is appropriate to
consider age as a potential confounding variable. The
effect of age was explored in some of the studies that used
QOL as a main outcome measure [37,38,41]. Reference to
established norms would have facilitated interpretation of
these results.
Only a few of the studies evaluated had explored the effect
of gender. Furthermore, their results were contradictory,
with gender being more detrimental to the QOL of
women in some cases [41,58] and men, in others [51].
Little has been reported about the effects of other poten-
tial confounding variables (e.g., socio-demographic and
economic data, health habits, social support, number of
drugs prescribed), although these factors are recognized as
having an impact on QOL [68-71]. A few of the studies
that used QOL as a secondary outcome measure consid-
ered the influence of socio-economic variables; however,
their results were ambiguous, showing an impact in only
about half of the studies. Some studies also demonstrated
that, although socio-economic variables and health habits
were significant predictors of QOL, the number of comor-
bidities was the strongest independent predictor of QOL
[41,56]. Only one study took into account social support,
and this study revealed a relationship with the mental
dimension of QOL [58]. Only one study took into
account the number of drugs prescribed and found an
impact on the physical domain of QOL [49]. This study
looked specifically at comorbidities associated with arte-
rial hypertension and their impact on QOL. Finally, other
potential confounding variables such as marital status and
living arrangements were considered in some studies,
with demonstration of an impact on QOL in about half
the studies.
Many other factors should be explored in this regard. For
example, the presence of coexisting acute conditions, the
time since the diagnosis of important chronic conditions,
and the duration and prognosis of health problems are
among factors that may explain some of the variability in
QOL or HRQOL.
Research agenda
In light of the findings of this systematic review, further
research is needed to clarify the relationship between mul-
timorbidity and QOL. The early work will certainly be
conceptual and theoretical. The resultant conceptual clar-
ity would benefit both researchers and practitioners. How
do we define and how should we measure multimorbidity
are among the first questions to be addressed. More
descriptive studies, which take into account the influence
of multiple potential confounders, can then be con-
ducted. Multivariate analyses will help control for the
effects of these confounding variables. The effects of age
and gender also need to be further explored, with refer-
ence to established norms. Although there is still a need
for cross-sectional studies, longitudinal studies are also
needed to identify changes in the relationship between
multimorbidity and QOL over time.
Study limitations
The main limitation of a systematic review is its inability
to include all of the relevant literature. We realize that
some articles may have been missed during the search
stage. However, our review of a huge number of abstracts
generated by different strategies improved the sensitivity
of the search. Obviously, the absence of a keyword for
multimorbidity is a limitation. However, we found that in
the majority of cases in which the term "multimorbidity"
was used to search, the term "comorbidity" also appeared
in the list of keywords. Adding the term "chronic disease"
also helped to circumvent the problem. Restricting theHealth and Quality of Life Outcomes 2004, 2:51 http://www.hqlo.com/content/2/1/51
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search to articles published in French or English is another
limitation.
Conclusion
This systematic review focused on the relationship
between the presence of several chronic coexisting medi-
cal conditions and QOL or HRQOL in a primary care
setting. However, the studies evaluated had important
limitations due to the lack of a uniform definition for
multimorbidity or comorbidity, the absence of assess-
ment of disease severity, the use of self-reported diag-
noses, and the frequent exclusion of psychiatric
diagnoses. The potential impact of important confound-
ing variables was also neglected. In light of these observa-
tions, it seems clear that further studies are needed to
clarify the impact of multimorbidity on QOL or HRQOL
and its various dimensions (i.e., physical, social and psy-
chological). A clear understanding of this relationship will
ultimately help both researchers and primary health care
professionals to deliver more comprehensive care.
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